Tapewire

Nasdaq · USD

LIVN

LivaNova PLC

Export transactions ↓
Tapewire entity
507
SEC CIK
0001639691
Parsed reports
465

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 202602
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2024 Filed Sep 17, 2024 16:05 UTC
Poletti FrancoPresident, Cardiopulmonary
GrantPerformance Stock Units · Derivative 1,287 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000123 · wk-form4_1726603520.xml · derivative · entry 2

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,287

Underlying: Ordinary Shares · 1,287 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement.

F4 · derivative.exercise_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F4 · derivative.expiration_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
September 15, 2024 Filed Sep 17, 2024 16:05 UTC
Poletti FrancoPresident, Cardiopulmonary
GrantRestricted Stock Units · Derivative 2,575 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000123 · wk-form4_1726603520.xml · derivative · entry 1

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,575

Underlying: Ordinary Shares · 2,575 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of LivaNova PLC (the "Company"), GBP 1.00 par value, in accordance with the terms of the Company's 2022 Incentive Award Plan (the "Plan") and the award agreement.

F2 · derivative.exercise_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F2 · derivative.expiration_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 20:13 UTC SaleOrdinary Shares 1,500 $46.58 $69,870.00
Disclosure

SEC source: 0001639691-24-000119 · wk-form4_1726258430.xml · nonDerivative · entry 1

Bianchi Francesco · CIK 0001656080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,772

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC
Tezel AhmetChief Innovation Officer
GrantStock Appreciation Rights · Derivative 25,383 $0.00 Strike: $52.68 $0.00
Disclosure

SEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 5

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,383

Underlying: Ordinary Shares · 25,383 shares

Expires 2034-06-15

F7 · derivative.exercise_date: On June 15, 2024, reporting person was granted stock appreciation rights ("SARs") subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC
Tezel AhmetChief Innovation Officer
GrantPerformance Stock Units · Derivative 7,118 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 4

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,118

Underlying: Ordinary Shares · 7,118 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement.

F6 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F6 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC
Tezel AhmetChief Innovation Officer
GrantPerformance Stock Units · Derivative 3,559 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 3

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,559

Underlying: Ordinary Shares · 3,559 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement.

F5 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC
Tezel AhmetChief Innovation Officer
GrantPerformance Stock Units · Derivative 3,559 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 2

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,559

Underlying: Ordinary Shares · 3,559 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement.

F4 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F4 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC
Tezel AhmetChief Innovation Officer
GrantRestricted Stock Units · Derivative 11,863 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 1

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,863

Underlying: Ordinary Shares · 11,863 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of LivaNova PLC ("the Company") GBP 1.00 par value in accordance with the terms of the Company's 2022 Incentive Award Plan ("the Plan") and the award agreement.

F2 · derivative.exercise_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F2 · derivative.expiration_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC
Story BrookeDirector
GrantRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · derivative · entry 4

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,416

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC
Story BrookeDirector
Exercise / conversionRestricted Stock Units · Derivative 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · derivative · entry 3

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC
Story BrookeDirector
Tax withholdingOrdinary Shares 584 $52.68 $30,765.12
Disclosure

SEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · nonDerivative · entry 2

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,476

F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC
Story BrookeDirector
Exercise / conversionOrdinary Shares 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · nonDerivative · entry 1

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,060

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC GrantRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000100 · wk-form4_1718741210.xml · derivative · entry 1

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,416

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F2 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F2 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC GrantRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · derivative · entry 4

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,416

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F5 · derivative.exercise_date: The RSUS vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: The RSUS vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionRestricted Stock Units · Derivative 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · derivative · entry 3

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Tax withholdingOrdinary Shares 585 $52.68 $30,817.80
Disclosure

SEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · nonDerivative · entry 2

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,732

F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionOrdinary Shares 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · nonDerivative · entry 1

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC GrantRestricted Stock Units · Derivative 4,840 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000093 · wk-form4_1718741130.xml · derivative · entry 1

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,840

Underlying: Ordinary Shares · 4,840 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F2 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F2 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC GrantRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · derivative · entry 4

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,416

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC Exercise / conversionRestricted Stock Units · Derivative 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · derivative · entry 3

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC Tax withholdingOrdinary Shares 586 $52.68 $30,870.48
Disclosure

SEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · nonDerivative · entry 2

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,057

F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC Exercise / conversionOrdinary Shares 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · nonDerivative · entry 1

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,643

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC GrantRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · derivative · entry 4

Enxing Seng Stacy · CIK 0001329921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,416

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionRestricted Stock Units · Derivative 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · derivative · entry 3

Enxing Seng Stacy · CIK 0001329921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Tax withholdingOrdinary Shares 585 $52.68 $30,817.80
Disclosure

SEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · nonDerivative · entry 2

Enxing Seng Stacy · CIK 0001329921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,745

F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionOrdinary Shares 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · nonDerivative · entry 1

Enxing Seng Stacy · CIK 0001329921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionRestricted Stock Units · Derivative 1,576 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000096 · wk-form4_1718741164.xml · derivative · entry 3

Shvartsburg Alex · CIK 0001830830 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,576 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ('the Plan') and the award agreement.

F4 · derivative.exercise_date: On June 15, 2020, reporting person was granted RSUs subject to a four-year vesting schedule, the final vesting for which occurred June 15, 2024.

F4 · derivative.expiration_date: On June 15, 2020, reporting person was granted RSUs subject to a four-year vesting schedule, the final vesting for which occurred June 15, 2024.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Tax withholdingOrdinary Shares 670 $52.68 $35,295.60
Disclosure

SEC source: 0001639691-24-000096 · wk-form4_1718741164.xml · nonDerivative · entry 2

Shvartsburg Alex · CIK 0001830830 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,729

F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionOrdinary Shares 1,576 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000096 · wk-form4_1718741164.xml · nonDerivative · entry 1

Shvartsburg Alex · CIK 0001830830 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ('RSUs') settled into ordinary shares of LivaNova PLC ('the Company'), GBP 1.00 par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ('the Plan') and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC GrantRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · derivative · entry 4

Bianchi Francesco · CIK 0001656080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,416

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionRestricted Stock Units · Derivative 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · derivative · entry 3

Bianchi Francesco · CIK 0001656080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Tax withholdingOrdinary Shares 585 $52.68 $30,817.80
Disclosure

SEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · nonDerivative · entry 2

Bianchi Francesco · CIK 0001656080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,272

F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC Exercise / conversionOrdinary Shares 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · nonDerivative · entry 1

Bianchi Francesco · CIK 0001656080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC GrantRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · derivative · entry 4

O'Kane Sharon · CIK 0001655980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,416

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC Exercise / conversionRestricted Stock Units · Derivative 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · derivative · entry 3

O'Kane Sharon · CIK 0001655980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC Tax withholdingOrdinary Shares 1,260 $52.68 $66,376.80
Disclosure

SEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · nonDerivative · entry 2

O'Kane Sharon · CIK 0001655980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,494

F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:05 UTC Exercise / conversionOrdinary Shares 2,680 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · nonDerivative · entry 1

O'Kane Sharon · CIK 0001655980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 16:03 UTC Exercise / conversionOption to purchase shares · Derivative 56,623 $0.00 Strike: $57.39 $0.00
Disclosure

SEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · derivative · entry 4

Moore Daniel Jeffrey · CIK 0001400857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 56,623 shares

Expires 2024-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of the option occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021.

F5 · derivative.expiration_date: The Form 3 filed on behalf of the reporting person on October 22, 2015 contained a typo in the expiration date for this option. This option expires on June 15, 2024.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 16:03 UTC SaleOrdinary Shares 2,045 $61.09 $124,920.87
Disclosure

SEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · nonDerivative · entry 3

Moore Daniel Jeffrey · CIK 0001400857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,534

F2 · kind: The sale of the ordinary shares occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.829 to $61.290, inclusive. The reporting person undertakes to provide to LivaNova PLC, any security holder of LivaNova PLC, or the staff of the Securities and Exchange Commission, upon request, the information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 16:03 UTC SaleOrdinary Shares 54,578 $60.08 $3,278,773.35
Disclosure

SEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · nonDerivative · entry 2

Moore Daniel Jeffrey · CIK 0001400857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,579

F2 · kind: The sale of the ordinary shares occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.75 to $60.610, inclusive. The reporting person undertakes to provide to LivaNova PLC, any security holder of LivaNova PLC, or the staff of the Securities and Exchange Commission, upon request, the information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 16:03 UTC Exercise / conversionOrdinary Shares 56,623 $57.39 $3,249,593.97
Disclosure

SEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · nonDerivative · entry 1

Moore Daniel Jeffrey · CIK 0001400857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of the option occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:20 UTC
Makatsaria VladimirDirector · Chief Executive Officer
GrantStock Appreciation Rights · Derivative 29,309 $0.00 Strike: $55.94 $0.00
Disclosure

SEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 7

Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,309

Underlying: Ordinary Shares · 29,309 shares

Expires not disclosed

F7 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F7 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:20 UTC
Makatsaria VladimirDirector · Chief Executive Officer
GrantStock Appreciation Rights · Derivative 52,268 $0.00 Strike: $55.94 $0.00
Disclosure

SEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 6

Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,268

Underlying: Ordinary Shares · 52,268 shares

Expires not disclosed

F7 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F7 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:20 UTC
Makatsaria VladimirDirector · Chief Executive Officer
GrantPerformance Stock Units · Derivative 23,909 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 5

Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,909

Underlying: Ordinary Shares · 23,909 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F6 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F6 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:20 UTC
Makatsaria VladimirDirector · Chief Executive Officer
GrantPerformance Stock Units · Derivative 11,954 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 4

Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,954

Underlying: Ordinary Shares · 11,954 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F5 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:20 UTC
Makatsaria VladimirDirector · Chief Executive Officer
GrantPerformance Stock Units · Derivative 11,954 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 3

Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,954

Underlying: Ordinary Shares · 11,954 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F4 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F4 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:20 UTC
Makatsaria VladimirDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 23,909 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 2

Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,909

Underlying: Ordinary Shares · 23,909 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F2 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F2 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:20 UTC
Makatsaria VladimirDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 13,407 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 1

Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,407

Underlying: Ordinary Shares · 13,407 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F2 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F2 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:22 UTC
Bolton StephaniePresident, Global Epilepsy
GrantStock Appreciation Rights · Derivative 10,746 $0.00 Strike: $55.94 $0.00
Disclosure

SEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 14

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,746

Underlying: Ordinary Shares · 10,746 shares

Expires not disclosed

F18 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F18 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:22 UTC
Bolton StephaniePresident, Global Epilepsy
GrantPerformance Stock Units · Derivative 4,915 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 13

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,915

Underlying: Ordinary Shares · 4,915 shares

Expires not disclosed

F14 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F17 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F17 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.